Artichoke phytocomplex modulates serum micrornas in patients exposed to asbestos: a first step of a phase ii clinical trial

HIGHLIGHTS

  • who: Paola Muti from the Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy have published the research work: Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial, in the Journal: (JOURNAL) of 12/05/2022
  • what: The authors tested biological activity and toxicity of an freeze-dried extract (AWPC) as potential complementary preventive/early stage treatment agent for This phase II clinical study then was conducted in 18 male-patients with evidence of radiographic characteristics related to asbestos exposure such as . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?